For drugmaker and consumer products leader Johnson & Johnson (JNJ), the premarket proved unsettled ground after announcing quarterly earnings. Losses hit over 3% despite a mixed-bag report, but the losses ultimately reversed, and gains continued into Tuesday's trading. The stock is now up over 3%. I remain bullish on Johnson & Johnson; the company's presence in COVID-19 fighting is sound on its own, but that's barely the tip of the iceberg for Johnson & Johnson products. The last year for Johnson & Johnson shares has been, overall, upward, though not without some losses along the way. The company started off last April struggling to stay above $160 per share.
https://www.tipranks.com/news/article/johnson-johnsons-mixed-earnings-report-prompts-volatile-swings?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Johnson and Johnson Charts.